CIK 0001422142
- Non-accelerated filer
- Smaller reporting company
Whitehawk Therapeutics, Inc.
Sign in to watch- Ticker
- WHWK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 611547850
- Phone
- +1 551-321-2234
- Business address
- 2 HEADQUARTERS PLAZA, EAST BUILDING, 11TH FLOOR, MORRISTOWN, NJ, 07960
- Former names
- Aadi Bioscience, Inc., Aerpio Pharmaceuticals, Inc., ZETA ACQUISITION CORP II
- 4 Grant or award Chief Medical Officer acquired 19,132 shares (grant or award)
- 4 Grant or award See remarks acquired 51,020 shares (grant or award)
- 4 Grant or award CHIEF FINANCIAL OFFICER acquired 38,265 shares (grant or award)
- 4 Grant or award CHIEF EXECUTIVE OFFICER acquired 51,021 shares (grant or award)
- 4 Grant or award Director acquired 255,102 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Open-market sale CHIEF FINANCIAL OFFICER sold 218,600 shares at an average $4.03 ($882,028)
- 4 Open-market sale See remarks sold 118,849 shares at an average $3.60 ($427,860)
- 4 Open-market sale See remarks sold 56,596 shares at an average $3.55 ($201,124)
- 4 Open-market sale CHIEF EXECUTIVE OFFICER sold 14,500 shares at $3.38 ($49,010)
- 4 Open-market sale CHIEF EXECUTIVE OFFICER sold 260,427 shares at an average $3.45 ($899,538)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Option exercise See remarks acquired 366,532 shares (option exercise)
- 4 Option exercise CHIEF FINANCIAL OFFICER acquired 473,902 shares (option exercise)
- 4 Open-market sale CHIEF EXECUTIVE OFFICER sold 26,858 shares at $3.48 ($93,466)
- 4 Open-market sale CHIEF EXECUTIVE OFFICER sold 5,100 shares at $3.31 ($16,879)
- 4 Open-market sale CHIEF FINANCIAL OFFICER sold 2,594 shares at $3.31 ($8,585)
- 4 Open-market sale See remarks sold 1,834 shares at $3.31 ($6,070)
- 4 Derivatives Options or other derivatives
Page 2 of 14 · 263 filings